References
Sadamatsu K, Tashiro H, Yoshida K, Shikada T, Iwamoto K, Morishige K, Yoshidomi Y, Tokunou T, Tanaka H. Acute effects of isosorbide dinitrate and nicorandil on the coronary slow flow phenomenon. Am J Cardiovasc Drugs. 2010;10:203–8.
Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, Palloshi A, Gianolli L, Calori G, Fazio F, Margonato A. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis. Int J Cardiol. 2009;137:137–44.
Sadr-Ameli MA, Saedi S, Saedi T, Madani M, Esmaeili M, Ghardoost B. Coronary slow flow: benign or ominous? Anatol J Cardiol. 2015;15:531–5.
Sharif-Yakan A, Nienaber CA. Pharmacological management of cardiac syndrome Y: a focused review. Angiol Open Access. 2015;3:143.
Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012;33:2771–81.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sadamatsu, K., Koga, Y. & Tashiro, H. Long-Term Follow-up of Patients with Coronary Slow Flow Phenomenon. Am J Cardiovasc Drugs 18, 73–74 (2018). https://doi.org/10.1007/s40256-017-0241-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-017-0241-4